31-45 of 49

Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
CME/CE Broadcast ReplayPulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes

Updates From the 7th World Symposium Task Force
CME/CEUpdates From the 7th World Symposium Task Force

Updates on Pulmonary Hypertension Clinical Trials
MinuteCE®Updates on Pulmonary Hypertension Clinical Trials
- advertisement

Macitentan Update: Impact on Management of Pulmonary Hypertension
MinuteCE®Macitentan Update: Impact on Management of Pulmonary Hypertension

Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
MinuteCE®Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

Advances in Minimally Invasive Screening for Lung Cancer
CME/CEAdvances in Minimally Invasive Screening for Lung Cancer

Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CEExpert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
- advertisement

TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
CME/CETROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use

Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps
CME/CESniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps

Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease
CME/CEClinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease




































































